Anti-anxiety activity: In vitro inhibitory activity of the endocannabinoid system through the inhibition of the fatty acid amide hydrolase (FAAH) and the monoacylglycerol lipase (MAGL) enzymesFAAH enzyme2: No inhibition3: IC50 = 38.29 ± 6.18 μMJZL 195 (positive control): 0.045 ± 0.002 μMMAGL enzyme2: No inhibition3: No significant inhibitionJZL 195 (positive control): 0.71 ± 0.31 μM. The gene discussed is MGLL; the disease is Anxiety.